Notice to Extend the Submission Period to the National Cancer Institute (NCI) for PA-18-592, Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)
PA-18-592
Notice Number: NOT-CA-20-040
Key Dates
Release Date: March 20, 2020
PA-18-592
Issued by
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to inform interested applicants that the submission period to the National Cancer Institute (NCI) for PA-18-592 “Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp Clinical Trial Not Allowed)” has been extended in the fiscal year 2020.
The new submission period will now be February 1 April 30, 2020.
The NCI guidelines can be found here.
All other aspects of PA-18-592 remain unchanged.
Inquiries
Please direct all inquiries to:
Alison Lin, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6177
Email: [email protected]
Department of Health
and Human Services (HHS)
and Human Services (HHS)
